# US 2020/0402636 A1 · Subcutaneous Outpatient Management

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0402636 A1
- Document ID: US20200402636A1
- Status: Published application
- Kind: A1
- Application number: 17/010,436
- Filed: 2020-09-02
- Published: 2020-12-24
- Earliest claimed: 2014-10-27
- Assignees: Aseko, Inc.
- Applicants: Aseko, Inc.
- Inventors: Robert C Booth; Harry Hebblewhite
- Web page: https://patentgrep.com/patent/US20200402636A1

## CPC

- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/14503: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors (A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/4839: {combined with drug delivery}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- G16H 10/40: for data related to laboratory analysis, e.g. patient specimen analysis
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 20/17: delivered via infusion or injection
- G16H 20/60: relating to nutrition control, e.g. diets
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16Z 99/00: Subject matter not provided for in other main groups of this subclass
- A61M 2205/3303: Using a biosensor
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16Z: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR

## Abstract

A method includes receiving glucose data of a patient at a glucometer having a display. The glucose data includes a glucose measurement measured by the glucometer and a glucose time associated with the glucose measurement. The method also includes obtaining patient information associated with the patient that includes a target blood glucose for the patient and a correction factor. The method also includes when the glucose measurement of the patient exceeds the target blood glucose for the patient, calculating a correction dose of insulin based on a function of the glucose measurement of the patient, the target blood glucose for the patient, and the correction factor. The method also includes displaying the correction dose of insulin on the display of the glucometer.

## Claims

### Claim 1

A glucometer comprising:
a display;
data processing hardware in communication with the data processing hardware; and
memory hardware in communication with the data processing hardware, the memory hardware storing instructions that when executed on the data processing hardware cause the data processing hardware to perform operations comprising:
receiving glucose data of a patient, the glucose data comprising a glucose measurement measured by the glucometer and a glucose time associated with the glucose measurement;
obtaining patient information associated with the patient, the patient information comprising a target blood glucose for the patient and a correction factor;
determining whether the glucose measurement of the patient exceeds the target blood glucose for the patient;
when the glucose measurement of the patient exceeds the target blood glucose for the patient, calculating a correction dose of insulin based on a function of the glucose measurement of the patient, the target blood glucose for the patient, and the correction factor;
displaying the correction dose of insulin on the display of the glucometer;
after the correction dose of insulin is administered to the patient, receiving a user input indication indicating selection of a button displayed on the display of the glucometer to record the correction dose of insulin administered to the patient; and
transmitting, via a network, to a remote computing system associated with a healthcare provider (HCP) of the patient, the received glucose data and a value of the correction dose of insulin administered to the patient.

### Claim 2 (depends on 1)

The glucometer of claim 1, wherein glucometer measures the glucose measurement using a test strip in communication with the glucometer.

### Claim 3 (depends on 1)

The glucometer of claim 1, wherein the operations further comprise executing a software application to calculate the correction dose of insulin based on the function of the glucose measurement of the patient, the target blood glucose for the patient, and the correction factor.

### Claim 4 (depends on 1)

The glucometer of claim 1, wherein obtaining the patient information comprises receiving the patient information from the remote computing system associated with the HCP of the patient, the patient information input to the remote computing system by the HCP of the patient.

### Claim 5 (depends on 1)

The glucometer of claim 1, wherein the operations further comprise:
receiving a number of carbohydrates for a current meal consumed by the patient;
calculating a recommended meal bolus based on the number of carbohydrates consumed by the patient; and
displaying the recommended meal bolus on the display of the glucometer.

### Claim 6 (depends on 5)

The glucometer of claim 5, wherein:
the patient information further comprises a carbohydrate-to-insulin ratio (CIR) for the patient, and
calculating the recommended meal bolus is further based on CIR for the patient.

### Claim 7 (depends on 1)

The glucometer of claim 1, wherein the operations further comprise:
aggregating one or more glucose measurements associated with a breakfast glucose time interval to determine a representative aggregate breakfast glucose measurement for the patient;
aggregating one or more glucose measurements associated with a midsleep glucose time interval to determine a representative aggregate midsleep glucose measurement;
selecting a governing glucose measurement as a lesser one of the representative aggregate midsleep glucose measurement or the representative aggregate breakfast glucose measurement;
determining an adjustment factor for adjusting a next recommended basal dosage based on the selected governing glucose measurement;
obtaining a previous day recommended basal dosage, and
determining the next recommended basal dosage by multiplying the adjustment factor times the previous day recommended basal dosage.

### Claim 8 (depends on 7)

The glucometer of claim 7, wherein the operations further comprise displaying the next recommended basal dosage on the display of the glucometer.

### Claim 9 (depends on 1)

The glucometer of claim 1, wherein the operations further comprise transmitting the correction dose to an administration device in communication with the data processing hardware, the administration device comprising:
a doser; and
an administration computing device in communication with the doser, the administration computing device configured to automatically dial in a number of units of insulin for the correction dose and cause the doser to administer the number of units of insulin for the correction dose.

### Claim 10 (depends on 1)

The glucometer of claim 1, wherein the operations further comprise displaying a notification on the display of the glucometer indicating when a next glucose measurement from the patient is required.

### Claim 11

A method comprising:
receiving, at data processing hardware of a glucometer, glucose data of a patient, the glucose data comprising a glucose measurement measured by the glucometer and a glucose time associated with the glucose measurement;
obtaining, by the data processing hardware, patient information associated with the patient, the patient information comprising a target blood glucose for the patient and a correction factor;
determining whether the glucose measurement of the patient exceeds the target blood glucose for the patient;
when the glucose measurement of the patient exceeds the target blood glucose for the patient, calculating, by the data processing hardware, a correction dose of insulin based on a function of the glucose measurement of the patient, the target blood glucose for the patient, and the correction factor;
displaying, by the data processing hardware, the correction dose of insulin on a display of the glucometer;
after the correction dose of insulin is administered to the patient, receiving, at the data processing hardware, a user input indication indicating selection of a button displayed on the display of the glucometer to record the correction dose of insulin administered to the patient; and
transmitting, via a network, from the data processing hardware to a remote computing system associated with a healthcare provider (HCP) of the patient, the received glucose data and a value of the correction dose of insulin administered to the patient.

### Claim 12 (depends on 11)

The method of claim 11, wherein glucometer measures the glucose measurement using a test strip in communication with the glucometer.

### Claim 13 (depends on 11)

The method of claim 11, executing, by the data processing hardware, a software application to calculate the correction dose of insulin based on the function of the glucose measurement of the patient, the target blood glucose for the patient, and the correction factor.

### Claim 14 (depends on 11)

The method of claim 11, wherein obtaining the patient information comprises receiving the patient information from the remote computing system associated with the HCP of the patient, the patient information input to the remote computing system by the HCP of the patient.

### Claim 15 (depends on 11)

The method of claim 11, further comprising:
receiving, at the data processing hardware, a number of carbohydrates consumed by the patient;
calculating, by the data processing hardware, a recommended meal bolus based on the number of carbohydrates consumed by the patient; and
displaying, by the data processing hardware, the recommended meal bolus on the display of the glucometer.

### Claim 16 (depends on 15)

The method of claim 15, wherein:
the patient information further comprises a carbohydrate-to-insulin ratio (CIR) for the patient; and
calculating the recommended meal bolus is further based on CIR for the patient.

### Claim 17 (depends on 11)

The method of claim 11, further comprising:
aggregating, by the data processing hardware, one or more glucose measurements associated with a breakfast glucose time interval to determine a representative aggregate breakfast glucose measurement for the patient,
aggregating, by the data processing hardware, one or more glucose measurements associated with a midsleep glucose time interval to determine a representative aggregate midsleep glucose measurement;
selecting, by the data processing, a governing glucose measurement as a lesser one of the representative aggregate midsleep glucose measurement or the representative aggregate breakfast glucose measurement;
determining, by the data processing hardware, an adjustment factor for adjusting a next recommended basal dosage based on the selected governing glucose measurement;
obtaining, by the data processing hardware, a previous day recommended basal dosage; and
determining, by the data processing hardware, the next recommended basal dosage by multiplying the adjustment factor times the previous day recommended basal dosage.

### Claim 18 (depends on 17)

The method of claim 17, further comprising displaying, by the data processing hardware, the next recommended basal dosage on the display of the glucometer.

### Claim 19 (depends on 11)

The method of claim 11, further comprising transmitting the correction dose from the data processing hardware to an administration device in communication with the data processing hardware, the administration device comprising:
a doser; and
an administration computing device in communication with the doser, the administration computing device configured to automatically dial in a number of units of insulin for the correction dose and cause the doser to administer the number of units of insulin for the correction dose.

### Claim 20 (depends on 11)

The method of claim 11, further comprising displaying, by the data processing hardware, a notification on the display of the glucometer indicating when a next glucose measurement from the patient is required.
